Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afimoxifene topical gel in women with mammographically dense breast
NCT03063619Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2018
- Primary completion
- Oct 2021
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of afimoxifene in breast cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Jan 2018; status: completed.
02
Drugs
afimoxifene
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03063619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03063619.